CYP4F22 Gene Mutations in Patients with Autosomal Recessive Congenital Ichthyosis Identification of Two Novel Mutations
PDF
Cite
Share
Request
Original Article
P: 90-94
December 2020

CYP4F22 Gene Mutations in Patients with Autosomal Recessive Congenital Ichthyosis Identification of Two Novel Mutations

Turk J Dermatol 2020;14(4):90-94
1. Department of Medical Genetics, Marmara University Pendik Training and Research Hospital, Istanbul, Turkey
2. Department of Medical Genetics, Ege University Faculty of Medicine, Izmir, Turkey
3. Department of Dermatology, Ege University Faculty of Medicine, Izmir, Turkey
4. Department of Medical Genetics, Dokuz Eylul University Faculty of Medicine, Izmir, Turkey
5. Department of Medical Genetics, Dr. Behcet Uz Children's Hospital, Izmir, Turkey
No information available.
No information available
PDF
Cite
Share
Request

ABSTRACT

Background:

Autosomal recessive congenital ichthyosis (ARCI) is a genetically heterogeneous keratinization disorder, which is clinically classified into five main forms: Lamellar ichthyosis, congenital ichthyosiform erythroderma, harlequin ichthyosis, self-healing collodion baby, and bathing suit ichthyosis. Mutations in TGM1, ABCA12, ALOX12B, ALOXE3, NIPAL4, CYP4F22, PNPLA1, LIPN, and CERS3 genes have been described in patients with ARCI. However, in 20% of the ARCI patients, the genetic defect remains unknown.

Materials and Methods:

In this study, we investigated the mutations in the CYP4F22 gene in ARCI patients who do not have mutations in two common ARCI genes, NIPAL4 and TGM1. Twenty-two patients diagnosed with ARCI and having no mutations in TGM1 and NIPAL4 genes were included in the study. Their CYP4F22 genes were sequenced using the Sanger sequencing method.

Results:

In 5 of 22 (22.7%) ARCI patients, four different mutations, of which two were previously reported, were found. The two novel mutations were c.976C> T and c.1189C> T. The c.727C> T and c.1303C>T mutations were previously reported.

Conclusions:

This study expands the CYP4F22 mutation spectrum and to provide more accurate genetic counseling for patients at risk.

Article is only available in PDF format. Show PDF
2024 ©️ Galenos Publishing House